Doron Therapeutics · 1 day ago
Director of Clinical Operations (fractional) - Hybrid in Chapel Hill, NC
Doron Therapeutics is a clinical-stage biotechnology company focused on developing innovative biologic therapies for osteoarthritis. The Director of Clinical Operations will provide strategic and hands-on leadership for the planning, execution, and oversight of clinical trials, ensuring high-quality execution through effective collaboration and management of CROs and external vendors.
Biotechnology
Responsibilities
Lead the operational planning and execution of Doron’s Phase 3 clinical development programs
Develop and manage clinical operations plans, timelines, budgets, and risk mitigation strategies
Ensure trials are conducted in compliance with ICH-GCP, FDA regulations, and applicable global regulatory requirements
Select, oversee, and manage CROs and clinical vendors to ensure high-quality deliverables and adherence to timelines and budgets
Serve as the primary operational point of contact for CROs, fostering strong partnerships while driving accountability
Review and approve CRO work plans, monitoring plans, and key operational metrics
Select and monitor appropriate KPI’s to ensure timely and on budget execution
Oversee site identification, activation, enrollment, retention, and close-out activities
Monitor study performance metrics and proactively address enrollment or operational challenges
Ensure inspection of readiness and support audits and regulatory inspections
Develop and manage clinical operations budgets, forecasts, and vendor invoices
Optimize resource utilization while maintaining trial quality and patient safety
Qualification
Required
Bachelor's degree in life sciences or a related field; advanced degree preferred
10+ years of clinical operations experience within biotech, pharmaceutical, or CRO environments
Demonstrated experience with late-stage (Phase 2/3) clinical trials
Proven experience managing CROs and external vendors
Strong working knowledge of FDA and international regulatory regulations, and global clinical trial requirements
Experience partnering cross-functionally with CMC, Quality, and external manufacturing organizations to support clinical supply and late-stage development
Ability to operate both strategically and tactically in a lean organization
Can do, hands-on, problem-solving attitude; ability to effectively and collaboratively operate in a lean environment
Benefits
Access to monthly health care stipend
Equity participation
Company
Doron Therapeutics
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drug derived from placental tissue.
Funding
Current Stage
Early StageTotal Funding
$11MKey Investors
SPRIM Global Investments
2024-11-25Series A· $11M
Recent News
Venture Capital Access Online
2024-12-02
Company data provided by crunchbase